Aclaris Therapeutics

+$0.91 (+6.58%) Today
-$0.01 (-0.07%) As of 8:28 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.

About ACRS

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments.

CEO
Neal S. Walker
Employees
77
Headquarters
Wayne, Pennsylvania
Founded
2012

ACRS Key Statistics

Market cap
981.42M
Price-Earnings ratio
—
Dividend yield
—
Average volume
582.90K
High today
$14.76
Low today
$13.45
Open price
$13.68
Volume
435.47K
52 Week high
$19.97
52 Week low
$9.26

ACRS News

Simply Wall StJul 4

Aclaris Therapeutics, Inc. insiders who sold US$1.6m worth of stock earlier this year are probably glad they did so as market cap slides to US$921m - Simply Wall St

Insiders seem to have made the most of their holdings by selling US$1.6m worth of Aclaris Therapeutics, Inc. ( ) stock at an average sell price of US$15.68 duri

ACRS Earnings

-$0.57
-$0.38
-$0.19
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure